SkyePharma Share Price (SKP)
| Bid price | 67.00 | Open price | 72.75 |
|---|---|---|---|
| Ask price | 73.00 | Prev close | 70.00 |
| High price | 72.75 | Spread | 8.22% |
| Low price | 67.45 | Volume | 7,505 |
Register now for FREE live SkyePharma share prices, SkyePharma stock quotes, charts, trades and FREE SkyePharma company fundamentals, market news and much much more. Why not upgrade to a premium service and get SkyePharma Level 2 Data, indepth research tools and investor commentary for SkyePharma (SKP) and other London Stock Exchange equities.
SkyePharma Share Price Chart
Register now for FREE SkyePharma share price charts
SkyePharma Share Price Information
| Name | SkyePharma | Epic | SKP |
|---|---|---|---|
| Activites | Researches and develops, manufactures and sells prescription pharmaceutical products | Reuters | SKP.L |
| ISIN | GB00B3BFNB64 | Google Finance | LON:SKP |
| Share Price (p) | 70.00 | Prev. Share Price (p) | 70.00 |
|---|---|---|---|
| Shares in Issue (m) | 24 | Market Cap (£m) | 17 |
| PE Ratio (x) | -5.36 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -6.70 | PEG |
Register now for FREE SkyePharma company fundamentals
SkyePharma Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 05/04/2012 | BUY | Peter Grant | CEO | 313 |
| 05/04/2012 | TIN | Peter Grant | CEO | 67 |
| 15/03/2012 | BUY | Peter Grant | CEO | 390 |
| 15/03/2012 | TIN | Peter Grant | CEO | 73 |
| 03/02/2012 | BUY | Peter Grant | CEO | 358 |
SkyePharma Company News
Result of AGM
/* */ RNS Number : 4822D Skyepharma PLC 16 May 2012 SKYEPHARMA PLC - RESULT OF AGM LONDON, UK, 16 May 2012 - SkyePharma PLC (LSE: SKP) announces the results of the voting by shareholders at the Annual General...
Skye Pharma confident Flutiform will boost revenues
Skye Pharma Group started 2012 with £15.2 million of cash and, as anticipated, received the U.S.$10 million (£6.2 million) milestone payment when Pacira achieved its first commercial sale of EXPAREL® in the US in April 2012. With the positive opinion on flutiform® adopted by the CHMP the Board...
FLASH: Skye Pharma confident Flutiform will boost revenues
Story provided by StockMarketWire.com
More SkyePharma Company News >>
Register now for FREE SkyePharma company news
SkyePharma Share Price Discussions
SkyePharma to report maiden profit in April ? (SKP)
Anybody else out there interested in these? 2002 Results are due in April, and they are expected to show a maiden profit. Last week I opened a small speculative long (spreadbet), but I am looking to add to this position a lot more if we get any sort of resolution over Iraq crisis before the...
incentives needed (SKP)
Oh dear, oh dear an EGM to give our fast-talking but slow-acting execs more incentive. Really...and what happened to the last swathe of incentive - did it die "on the vine" as it were through oversight...did I miss a return to 8op? No? you mean it's still about 25p like it was ages ago with...
SET TO SHOOT UP ? (SKP)
reasons: 1) Innovata are in merger talks with skypharma - (company has a valuation between 50-70p) and is currently trading on the lower end. 2) SkyePharma PLC ('the Company') Notification of Major Interest in Shares on 17th October 2005 by...
Register now for FREE SkyePharma share price discussions